Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norditropin for Cognitive Function in Retired NFL Players with GHD
NCT04121780Phase 2Recruiting
- Sponsor
- Center for Neurological Studies
- Start
- Oct 2019
- Primary completion
- Mar 2025
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Center for Neurological Studies. Primary endpoints: Cognitive functions - Working Memory at 1 year, Cognitive functions - Processing Speed at 1 year and 3 more. Started Oct 2019; status: recruiting.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT04121780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04121780.